SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-011844
Filing Date
2017-11-13
Accepted
2017-11-13 16:07:02
Documents
69
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0917_yewbiopharmgroup.htm 10-Q 657684
2 CERTIFICATION f10q0917ex31-1_yewbiopharm.htm EX-31.1 9803
3 CERTIFICATION f10q0917ex31-2_yewbiopharm.htm EX-31.2 9764
4 CERTIFICATION f10q0917ex32_yewbiopharm.htm EX-32 5089
  Complete submission text file 0001213900-17-011844.txt   4075596

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20170930.xml EX-101.INS 676572
6 XBRL SCHEMA FILE yewb-20170930.xsd EX-101.SCH 59886
7 XBRL CALCULATION FILE yewb-20170930_cal.xml EX-101.CAL 44741
8 XBRL DEFINITION FILE yewb-20170930_def.xml EX-101.DEF 145864
9 XBRL LABEL FILE yewb-20170930_lab.xml EX-101.LAB 471491
10 XBRL PRESENTATION FILE yewb-20170930_pre.xml EX-101.PRE 299653
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 171195882
SIC: 0100 Agricultural Production-Crops